Dr. Juliane Rademacher


Juliane Rademacher's scientific journey began at the Universities of Lübeck, Germany and Stockholm, Sweden, where she studied Molecular Life Sciences and Biochemistry, respectively. She prepared her Bachelor thesis about a structural aspect of a DNA repair mechanism at the LMB in Cambridge, UK, and her master thesis about transcriptional control in stem cells at the Salk Institute in La Jolla, USA.

She proceeded with her doctorate at the Max Delbrück Center in Berlin. She held a doctoral fellowship of the German-Israeli Helmholtz Research School "Frontiers in Cell Signaling and Gene Regulation". Her work focused on signaling of GPCRs and small GTPases of the Ras superfamily and their role in cell migration and cancer development.

As guest scientist at the MPI for Colloids and Interfaces in Potsdam, she evaluated targeted-delivery approaches by visualization of targeted liposomal uptake by confocal microscopy.

After that she transferred to business consulting, firstly with d-fine GmbH, where she was involved in digital transformation projects, and later as biopharma strategy consultant at Scitaris GmbH, where she assisted clients of the biotech and pharmaceutical industries to explore therapeutic and commercial opportunities. She was involved in a variety of projects, including in-depth indication searches for immuno-oncology drug candidates, broad M&A screens, or asset valuation.

As strategy and group development manager at Heartbeat labs, a company builder and investor in Berlin, she was responsible for the scientific and strategic evaluation of investment opportunities in the digital health and biopharma space, ranging from early-stage academic startups to post-IPO biotech companies. Juliane joined wings4innovation GmbH as Translational Guide in 2022 and is thrilled to continue to support scientists in translating their ideas to ultimately bring value to patients.